Small-molecule SUMO inhibition for biomarker-informed B-cell lymphoma therapy.
- DOI
- 10.3324/haematol.2022.280995
- Published
- 2023-02-01
- Container
- Haematologica
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3324/haematol.2022.280995,
title = {Small-molecule SUMO inhibition for biomarker-informed B-cell lymphoma therapy.},
author = {Demel UM and Wirth M and Yousefian S and Zhang L and Isaakidis K and Dönig J and Böger M and Singh N and Köse H and Haas S and Müller S and Schick M and Keller U.},
year = {2023},
journal = {Haematologica},
doi = {10.3324/haematol.2022.280995},
url = {https://doi.org/10.3324/haematol.2022.280995}
}RIS
TY - JOUR TI - Small-molecule SUMO inhibition for biomarker-informed B-cell lymphoma therapy. AU - Demel UM AU - Wirth M AU - Yousefian S AU - Zhang L AU - Isaakidis K AU - Dönig J AU - Böger M AU - Singh N AU - Köse H AU - Haas S AU - Müller S AU - Schick M AU - Keller U. PY - 2023 JO - Haematologica DO - 10.3324/haematol.2022.280995 UR - https://doi.org/10.3324/haematol.2022.280995 ER -
APA
UM, D., M, W., S, Y., L, Z., K, I., J, D., M, B., N, S., H, K., S, H., S, M., M, S., & U., K. (2023). Small-molecule SUMO inhibition for biomarker-informed B-cell lymphoma therapy.. Haematologica. https://doi.org/10.3324/haematol.2022.280995
Source records
- europe-pmc · retrieved 2026-09-27T10:47:36.305Z